Dr. Martens PLC Block Listing Application (4466N)
30 Septiembre 2021 - 2:44AM
UK Regulatory
TIDMDOCS
RNS Number : 4466N
Dr. Martens PLC
30 September 2021
30 September 2021
Dr. Martens plc (the "Company")
Block Listing application
The Company announces today that application has been made to
the FCA and to the London Stock Exchange for admission to (i) the
Official List and (ii) to trading on the London Stock Exchange's
main market for a block listing of securities in respect of a total
of 200,000 ordinary shares of GBP 0.01 each (the "Ordinary Shares")
in the Company. It is expected that admission will become effective
on 4 October 2021.
The Ordinary Shares are being reserved under a block listing and
will be issued under the Company's share plans.
The Company anticipates it will first use the Ordinary Shares
reserved under the block listing in connection with an all-employee
award of free shares in order to reward our teams and further align
our people with the long-term success of the business.
When issued the Ordinary Shares will rank pari passu in all
respects with the existing Ordinary Shares of the Company.
Enquiries:
Bethany Barnes, Director of Investor Relations
bethany.barnes@drmartens.com
Paul Rolling, Assistant Company Secretary
paul.rolling@drmartens.com
About Dr. Martens plc
Dr. Martens is an iconic British brand founded in 1960 in
Northamptonshire. Originally produced for workers looking for
tough, durable boots, the brand was quickly adopted by diverse
youth subcultures and associated musical movements. Dr. Martens
have since transcended their working-class roots while still
celebrating their proud heritage and, six decades later, "Docs" or
"DMs" are worn by people around the world who use them as a symbol
of empowerment and their own individual attitude.
The Company successfully listed on the main market of the London
Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of
the FTSE 250 index.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ALSLLMFTMTJTBRB
(END) Dow Jones Newswires
September 30, 2021 03:44 ET (07:44 GMT)
Dr. Martens (LSE:DOCS)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Dr. Martens (LSE:DOCS)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
